Results 131 to 140 of about 21,745 (193)

Lichenoid dermatosis after apalutamide treatment: Two case reports and literature review. [PDF]

JAAD Case Rep
Deitelzweig C, Raef H, Alzahrani N, Cheeley J.   +3 more
europepmc   +1 more source

Maculopapular-Type Drug Eruption Caused by Cetuximab. [PDF]

Cureus
Ikegawa N, Saito-Sasaki N, Sawada Y.
europepmc   +1 more source

Undifferentiated Purpuric and Desquamative Drug Eruption After Pembrolizumab and Empagliflozin Exposure: A Clinicopathologic Diagnostic Pitfall. [PDF]

Cureus
Biswas N, Khokhar I, Fu JJ.
europepmc   +1 more source

Apremilast combined with low-dose corticosteroids for lichenoid drug eruption following programmed cell death protein 1 inhibitor and lenvatinib therapy: A case report. [PDF]

JAAD Case Rep
Meng X, Li D, Zhou B, Liu J, Xu Y.
europepmc   +1 more source

Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases.

JAMA Dermatol, 2017
Cho YT, Chen KL, Sheen YS, Yang CW, Liau JY, Cheng YP, Chu CY.   +6 more
europepmc   +1 more source

Concurrent Drug-induced Rowell Syndrome and Acute Generalized Exanthematous Pustulosis. [PDF]

Acta Derm Venereol
Hsu YA, Chu KY, Lan CE.
europepmc   +1 more source

Probable metformin-associated erythema multiforme: a case report and practical reference to causality assessment. [PDF]

Front Endocrinol (Lausanne)
Luo L, Teng B.
europepmc   +1 more source

Dupilumab Can Be Effective for Immune-Related Adverse Event Dermatitis: A Case Report and Review of the Literature. [PDF]

Clin Cosmet Investig Dermatol
Mima Y, Yamamoto M, Chiba K, Iozumi K.
europepmc   +1 more source

Chemotherapy and the Skin: Understanding Dermatologic Side Effects. [PDF]

Cureus
Unnikrishnan P, Vudayana K, Diddi S, Akkineni US, Sri Koulini V, Gayathri C.   +5 more
europepmc   +1 more source